Enhancedanti-tumor efficacy through a combination of intramuscularly expressed dna vaccine and plasmid-encoded pd-1 antibody

HIGHLIGHTS

• who: Xun Liu from the Guangdong Medical University, China have published the paper: Enhancedanti-tumor efficacy through a combination of intramuscularly expressed DNA vaccine and plasmid-encoded PD-1 antibody, in the Journal: (JOURNAL)
• what: The authors show that OVA vaccines with a modified delivery route can increase the efficacy of ICI, and that the plasmid encoding a-PD-1 provides a safer and more economical treatment choice for major cancer patients. clinical trials . The authors explored the use DNA vaccine or plasmid encoded antibodies and the combined treatment of a-PD-1 with DNA . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.